Progesterone plays a central coordinate role in regulating reproductive events associated with the establishment and maintenance of pregnancy including ovulation, uterine and mammary gland development and tumorigenesis, and neurobehavioral expression associated with sexual responsiveness. The effects of progresterone are mediated by two receptor proteins (PR), termed A and B, that arise from a single gene and act as ligand-activated transcription factors to regulate the expression of reproductive target genes. Null mutation of both proteins in mice leads to pleiotropic reproductive abnormalities. This review summarizes the structure and functional properties of the PR isoforms and how functional differences between these proteins are likely to impact on the overall physiologic role of the receptor in reproductive systems.
3. Horwitz KB. Antiprogestins and the treatment of breast cancer. In: Donaldson MS, Dorflinger L, Brown SS, Benet LZ, eds. Clinical applications of mifepristone (RU486) and other antiprogestins. Washington, DC: National Academy Press, 1993:210-229.
4.
4. Evans RM. The steriod and thyroid hormone receptor superfamily. Science1988;240:889-895.
5.
5. Tsai M-J, O'Malley BW. Molecular mechanismsof action of steroid/thyroid receptor superfamily members. Ann Rev Biochem1994;63:451-486.
6.
6. Mangelsdorf DJ, Thummel C, Beato M, et al. The nuclear receptor superfamily: Overview of the second decade. Cell1995;83:835-839.
7.
7. O'Malley BW, Conneely OM. Minireview: Orphan receptors: In search of a unifying hypothesis for activation. Mol Endocrinol1992;6:1359-1361.
8.
8. Kastner P, Krust A, Turcotte B, et al. Two distinct estrogenregulated promoters generate transcripts encoding the two functionally different human progesterone receptor forms A and B. EMBO j1990;9:1603-1614.
9.
9. Kraus WL, Montano MM, Katzenellenbogen BS. Cloning of the rat progesterone receptor gene 5′-region and identification of two functionally distinct promoters. Mol Endocrinol1993;7:1603-1616.
10.
10. Allan GF, Leng HX, Tsai SY, et al. Hormone and antihormone induce distinct conformational changes which are central to steroid receptor activation. J Biol Chem1992;267:19513-19520.
11.
11. Allan GF, Tsai SY, Tsai M-J, et al. Hormonal induced conformational changes in the progesterone receptor are required for events following binding to DNA. Proc Natl Acad Sci USA1992;89:11750-11754.
12.
12. Guiochon-Mantel A, Loosfelt H, Lescop P, et al. Mechanisms of nuclear localization of the progesterone receptor: Evidence for interaction between monomers. Cell1989;57:1147-1154.
13.
13. Tsai SY, Carlstedt-Duke J, Weigel NL, et al. Molecular interactions of steroid hormone receptor with its enhancer element: Evidence for receptor dimer formation. Cell1988;55:361-369.
14.
14. Tsai M-J, O'Malley BW. Mechanisms of regulation of gene transcription by steroid receptors. In: Cohen P, Foulkes JH, eds. The hormonal control of gene expression. Amsterdam: Elsevier, 1991:101-116.
16. Weigel NL, Poletti A, Beck CA, et al. Phosphorylation and progesterone receptor function. In: Mondgil VK, ed. Hormones in health and disease. Boston: Birkhauser, 1993:309-332.
17.
17. Gronemeyer H. Transcription activation by estrogen and progesterone receptors. Ann Rev Genet1991;25:89-123.
18.
18. Onate SA, Tsai SY, Tsai M-J, et al. Sequence and characterization of a coactivator for the steroid hormone receptor superfamily. Science1995;270:1354-1357.
19.
19. Kamei Y, Xu L, Heinzel T, et al. A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors. Cell1996;485:403-414.
20.
20. Tora L, Gronemeyer H, Turcotte B, et al. The N-terminal region of the chicken progesterone receptor specifies target gene activation. Nature1988;333:185-188.
21.
21. Dobson ADW, Conneely OM, Beattie WG, et al. Mutationalanalysis of the chicken progesterone receptor. J Biol Chem1989;264:4207-4211.
22.
22. Meyer ME, Quirin-Stricker C, Lerouge T, et al. A limiting factor mediates the differential activation of promoters by the human progesterone receptor isoforms. J Biol Chem1992;267:10882-10887.
23.
23. Sartorius CA, Melville MY, Hovland AR, et al. A third transactivation function (AF3) of human progesterone receptors located in the unique N-terminal segment of the B-isoform. Mol Endocrinol1994;8:1347-1360.
24.
24. Luisi BF, Xu WX, Otwinowski Z, et al. Crystallographic analysis of the interaction of the glucocorticoid receptor with DNA. Nature1991;352:497-505.
25.
25. Fredman LP. Anatomy of the steroid receptor zinc finger region. Endocrime Rev1992;13:129-145.
26.
26. Picard D, Yamamoto KR. Two signals mediate hormonedependent nuclear localization of the glucocorticoid receptor. EMBO J1987;6:3333-3340.
27.
27. Hollenberg SM, Evans RM. Multiple and cooperative transactivation domains of the human glucocorticoid receptor. Cell1988;55:899-906.
28.
28. Webseter NJG, Green S, Jim J-R, et al. The hormone-binding remains of the estrogen and glucocorticoid receptors contain an inducible transcription activation function. Cell1988;54:199-207.
29.
29. Fawell SE, Lees JA, White R, et al. Characterization and colocalization of steroid binding and dimerization activities in the mouse estrogen receptor. Cell1990;60:953-962.
30.
30. Vegeto E, Allan GF, Schrader WT, et al. The mechanisms of RU486 antagonism is dependent on the conformation of the carboxy-terminal tail of the human progesterone receptor. Cell1992;69:703-713.
31.
31. Pratt WB, Jolly DJ, Pratt DV, et al. A region in the steroid binding domain determines formation of the non-DNA binding GS glucocorticoid receptor complex. J Biol Chem1988;263:267-272.
32.
32. Denner LA, Weigel NL, Maxwell BL, et al. Regulation of progesterone receptor-mediated transcription by phosphorylation. Science1990;250:1740-1743.
33.
33. Aronica SM, Katzenellenbogen BS. Progesterone receptor regulation in uterine cells: Stimulation by estrogen, cyclic adenosine 3′,5′-monophosphate, and insulin-like growth actor 1 and suppression by antiestrogens and protein kinase inhibitors. Endocrinology1991;128:2045-2052.
34.
34. Aronica SM, Katzenellenbogen BS. Stimulation of estrogen receptor-mediated transcription and alteration in the phosphorylation state of the rat uterine estrogen receptor by estrogen, cyclic adenosine monophosphate, and insulin-like growth factor-1. Mol Endocrinol1993;7:743-752.
36. Power RF, Lydon JP, Conneely OM, et al. Dopamine activation of an orphan member of the steroid receptor superfamily. Science1991;252:1546-1548.
37.
37. Power RF, Mani SK, Codina, J, et al. Dopaminergic and ligand-independent acivation of steroid hormone receptors. Science1991;254:1636-1639.
38.
38. Lydon JP, Power RF, Connectly OM. Differential modes of activation defineorphan subclasses within the steroid/thyroid receptor superfamily. Gene Express1992;2:273-283.
39.
39. Smith CL, Conneely OM, O'Malley BW. Modultion of the ligand-independent activation of the human estrogen receptor by hormone and antihormone. Proc Natl Acad Sci USA1993;90:6120-6124.
40.
40. Beck CA, Weigel NL, Moyer ML, et al. The progesterone antagonist RU486 acquies agonist activity upon stimulation of cAMP signaling pathways. Proc Natl Acad Sci USA1993;90:4441-4445.
41.
41. Sartorius CA, Trung L, Takimoto, et al. Antagonist-occupied human progesterone receptors bound to DNA are functionally switched to transcriptional agonists by cAMP. J Biol Chem1993;268:9262-9266.
42.
42. Mani SK, Allen JM, Clark JH, et al. Convergent pathways for steroid hormone- and neurotransmitter-induced rat sexual behavior. Science1994;265:1246-1249.
43.
43. Mani S, Allen JMC, Lydon JP, et al. Dopamine requires the unoccupied progesterone receptor in inducing sexual behavior inmice. Mol Endocrinol1996;10:1728-1737.
44.
44. McDonnell DP. Unraveling the human progesterone receptor signal trasduction pathway. Trends Endocrinol Metab1995;56:133-138.
45.
45. Horwitz KB. The molecular biology of RU4876. Is thee a role for antiprogestins in the treatment of breast cancer?Endocrine Revs1992;13:146-163.
46.
46. Bethea CL, Widmann AA. Differential expression of progestin receptor isoforms in the hypothalamus, pituitary, and endometrium of Rhesus macaques. The Endocrine Society1998;139:677-687.
47.
47. Schrader WT, O'Malley BW. Progesterone-binding components of chick oviduct. IV. Characterization of purified subunits. J Biol Chem1972;247:51-59.
48.
48. Shyamala G, Schneider W, Schott D. Developmental regulation of murine mammary progesterone receptor gene expression. Endocrinology1990;126:2882-2889.
49.
49. Feil PD, Clarke CL, Satyaswaroop PG. Progesterone receptor stucture and protease activity in primary human endometrial carcinoma. Cancer Res1988;48:1143-1147.
50.
50. Mangal RK, Wiehle RD, Poindexter AN III, et al. Differential expression of uterine progesterone receptor form A and B during the menstrual cycle. J Steroid Biochem Mol1997;63:195-202.
51.
51. Brandon DB, Bethea CL, Strawn EY, et al. Progesterone receptor messenger ribonucleic acid and protein are overexpressed in human uterine leiomyomas. J Obstet Gynecol1993;169:78-85.
52.
52. Natraj U, Richards JS. Hormonal regulation, localization, and functional activity of the progesterone receptor in granulosa cells of rat preovulatory follicles. Endocrinology1993;133:761-769.
53.
53. Graham JD, Yeates C, Balleine RL, et al. Progesterone receptor A and B protein expression in breast cancer. J Steroid Biochem Mol Bio1996;56:93-96.
54.
54. Vegeto E, Shahbaz MM, Wen DX, et al. Human progesterone receptor A form is a cell and promoter specific repressor of human progesterone receptor B function. Mol Endocrinol1993;7:1244-1255.
55.
55. Kraus WL, Weis KE, Katzenellenbogen BS. Inhibitory cross-talk between steroid hormone receptors: Differential targeting of estrogen receptor in repression of its transcriptional activity by agonist- and antagonist-occupied progestin receptors. Mol Cell Biol1995;15:1847-1857.
56.
56. McDonnell DP, Shabaz MM, Vegeto E, et all. The human progesterone receptor A-form functions as a transcriptional modulator of mineralocorticoid receptor activity. J Steroid Biochem Molec Biol1994;48:425-432.
57.
57. Wen DX, Xu Y-F, Mais DE, et al. The A and B isoforms of the human progesterone receptor operate through distinct signaling pathways within target cells. Mol Cell Biol1994;14:8356-8364.
58.
58. Sartorius CA, Groshong SD, Miller LA, et all. New T47D breast cancer cell lines for the independent study of progesterone B-and A-receptors: Only antiprogestin-occupied B-receptors are switched to transcriptional agonists by cAMP. Cancer Res1994;54:3868-3877.
59.
59. Musgrove EA, Hamilton JA, Lee CSL, et al. Growth factor, steroid, and steroid anatagonist regulation of cyclin gene expression associated with changes in T-47D human breast cancer cell cycle progression. Mol Cell Biol1993;13:3577-3587.
60.
60. McDonnell DP, Goldman ME. RU486 exerts antiestrogenic activities through a novels progesterone receptor A form-mediated mechanism. J Biol Chem1994;269:11945-11949.
61.
61. Kraus WL, Weis K, Katzenellenbogen BS. Determinants for the repression of estrogen receptor transcriptional activity by ligand-occupied progestin receptors. J Steroid Biochem Molec Biol1997;63:175-188.
62.
62. Foulkes NS, Sassone-Corsi P. More is better: Activators and repressors from the same gene. Cell1992;68:411-414.
63.
63. Anonymous. Alternative translation initiation site usage results in two functionally dinstinct forms of the GATA-1 transcription factor. Proc Natl Acad Sci USA1995;92:11598-11602.
64.
64. Schreiber E, Tobier A, Malipiero U, et al. cDNA cloning of human N-Oct3, a nervous system specific POU domain transcription factor binding to the octamer DNA motif. Nucleic Acids Res1993;21:253-258.
65.
65. Descombes P, Schibler U. A liver-enriched transcriptional activator protein, LAP, and a transcriptional inhibitory protein, LIP, are translated from the same mRNA. Cell1991;67:569-579.
66.
66. Rentoumis A, Chatterjeel VK, Madison LD, et al. Negative and positive transcription regulation by thyroid hormone receptor isoforms. Mol Endocrinol1990;4:1522-1531.
67.
67. Koenig RJ, Lazr MA, Hodin RA, et al. Inhibition of thyroid hormone action by a non-hormone bidning c-erbA protein generated by alternative mRNA splicing. Nature1989;337:659-661.
68.
68. Loutradis D, Bietsa R, Aravantinos L, et al. Preovulatory effects of the progesterone antagonist mifepristone (RU486) in mice. Hum Reprod1991;61:1238-1240.
69.
69. Park-Sarge O-K, Mayo KE. Regulation of progesterone receptor gene by gonadotropins and cyclic adenosine 3′,5′-monophosphate in rat granulosa cells. Endocrinology1994;134:709-718.
70.
70. Park-Sarge O-K, Mayo KE. Transient expression of progesterone receptor RNA in ovarian granulosa cells after the preovulatory luteinizing hormone surge. Mol Endocrinol1991;5:967-978.
71.
71. Natraj V, Richards JS. Hormonal regulation, localization, and functional activity ofthe progesterone receptor in granulosa cells of rat preovulaory follicles. Endocrinology1993;134:709-718.
72.
72. Jordan VC, Dix CJ. Effect of estradiola benzoate, tamoxifena and monohydroxytamoxifen on immature rat uterine progesterone receptor synthesis and endometrial cell division. J Steriod Biochem1979;11:285-291.
73.
73. Tibbets TA, Mendoza-Meneses M, O'Malley BW, et al. Mutual and intercompartmental regulation of estrogen and progesterone receptor expression in the mouse uterus. Biol Reprod1998;59:1143-1152.
74.
74. Martin L, Finn CA, Tringer G. Hypertrophy and hyperplasia in the mouse uterus after estrogen treatment: An autoradiographic study. J Endocrinol1973;56:133-144.
75.
75. Quarmby VE, Korach KS. The influence of 17 β-estradiol on patterns of cell division in the uterus. Endocrinology1984;114:694-702.
76.
76. Lubahn DB, Moyer JS, Golding TS, et al. Alteration of reproductive function but not prenatal sexual development after insertional disruption of the mouse estrogen receptor gene. Proc Natl Acad Sci USA1993;90:11162-11166.
77.
77. Kurita T, Young P, Brody JR, et al. Stromal progesterone receptors mediate the inhibitory effects of progesterone on estrogen-induced uterne epithelial cell deoxyribonucleic acid synthesis. Endocrinology1998;139:4708-4713.
78.
78. Martin L, Finn CA. Hormonal regulation of cell division in epithelial and connective tissues of the mouse uterus. J Endocrinol1968;41:363-371.
79.
79. Cullingford TE, Pollard JW. RU486 completely inhibits the action of progesterone on cell proliferation in the mouse uterus. J Reprod Fertil1988;83:909-914.
80.
80. Das KS, Tsukamara H, Paria GK, et al. Differential expression of epidermal growth factor receptor (EGFR) bioactivity by progeserone and estrogen in the adult mouse uterus. Endorcrinology1994;134:971-981.
81.
81. Paria BC, Das SK, Huet-Hudson YM, et al. Distribution of transforming growth factor a precursors in the mouse uterus during the periimplantation period and after steroid hormone treatments. Biol Reprod1994;50:481-491.
82.
82. Das SK, Chakroborty I, Paria BC, et al. Amphiregulin is an implanation-spefiic and progesterone-regulated gene in the mouse uterus. Mol Endocrinol1995;9:691-705.
83.
83. Kirkland JL, Murthy L, Stancel GM. Progesterone inhibits the estrogen-induced expression of c-fos messenger ribonucleic acid in the uterus. Endocrinology1992;130:3223-3230.
84.
84. Fink KL, Wieben ED, Woloschak GE, et al. Rapid regulation of c-myc protooncogene expression by progesteronein avian oviduct. Proc Natl Acad Sci USA1988;85:1796-1800.
85.
85. Ito A, Imada K, Takashi S, et al. Suppression of interleukin 8 production by progesterone in rabbit uterine cervix. Biochem J1994;301:183-186.
86.
86. Topper YJ, Freeman CS. Multiple hormone interactions in the developmental biology of the mammary gland. Physiol Rev1980;60:1049-1056.
87.
87. Henninghausen L, Robinson GW. Think globally, act locally: The making of a mouse mammary gland. Genes Dev1998;12:449-455.
88.
88. Imagawa W, Yang J, Guzman R, et al. Control of mammary gland development. In: Knobil E, Neill JD, eds. The physiology of reproduction. 2nd ed.New York: Raven Press, 1994;1033-1063.
89.
89. Daniel CW, Silberstein GB. Postnatal development of the rodent mammary gland. In: Neville MC, Daniel C, eds. The mammary gland development and function. New York: Plenum Publishing Inc., 1987;3-21.
90.
90. Cunha GR, Youn P, Hom YK, et al. Elucidation of a role for stroma steroid hormone receptors in mammary gland growth and development using tissue recombinants. J Mammary Gland Biol Neoplasia1997;2:393-402.
91.
91. Liu X, Robinson GW, Wagner KU, et al. Stat5a is mandatory for adult mammary gland development and lactogenesis. Genes Dev1997;11:179-186.
92.
92. Udy GB, Towers RP, Snell RG, et al. Requirement of STAT5b for sexual dimorphism of body growth rates and liver gene expression. Proc Natl Acad Sci USA1997;94:7239-7244.
93.
93. Robinson GW, Johnson PF, Henninghausen L, et al. The C/EBPβ transcription factor regulates epithelial cell proliferation and differentiation in the mammary gland. Genes Dev1998;15:1907-1916.
94.
94. Seagroves TN, Krnacik S, Raught B, et al. C/EPBβ, but not C/EBPα, is essential for ductal morphogenesis, lobuloalveolar proliferation, and functional differentiation in the mouse mammary gland. Genes Dev1928;12:1917-1928.
95.
95. Sicinski P, Donaher JL, Parker SB, et al. Cyclin D1 provides a link between development and oncogenesis in the retina and breast. Cell1995;82:621-630.
96.
96. Ormandy CJ, Camus A, Barra J, et al. Null mutation of the prolactin receptor gene produces multiple reproductive defects in the mouse. Genes Dev1997;11:167-178.
97.
97. Schaapveld RQJ, Schepens JTG, Robinson GW, et al. Impaired mammary gland development and function in mice lackingLAR receptor-like tyrosine phosphate activity. Dev Biol1997;188:134-146.
98.
98. Chen F, Capecchi MR. Paralogous mouse. Hox genes, Hoxa9, Hoxb9, and Hoxd9, function together to control development of the mammary gland in response to pregnancy. PNAS1999;96:541-546.
99.
99. Fowler KJ, Walker F, Alexander W, et al. A mutation in the epidermal growth actor receptor in waved-2 mice has a profound effect on receptor biochemistry that results in impaired lactation. Proc Natl Acad Sci USA1995;92:1465-1469.
100.
100. Lange CA, Richer JK, Shen T, et al. Convergence of progesterone with growth factor and cytokine signaling in breast cancer. J Biol Chem1998;273:31308-31316.
101.
101. Richer JK, Lange CA, Manning NG, et al. Convergence of progesterone with growth factor and cytokine signaling in breast cancer. J Biol Chem1998;273:31317-31326.
102.
102. Sutherland RL, Lee CSL, Feldman RS, et al. Regulation of breast cancer cell cycle progression by growth actors, steroids and steroid antagonists. J Steroid Biochem Mol Biol1992;41:315-321.
103.
103. Said TK, Conneely OM, Medina D, et al. Progesterone in addition to estrogen induces cyclin D1 expression in the mammary epithelial cell, in vivo. Endocrinology1997;138:3933-3939.
104.
104. Robinson SP, Jordan VC. Reversal of the antitumor effects of tamoxifen by progesterone in the 7,12-dimethyl benzanthracene-induced rat mammary carcinoma model. Cancer Res1987;47:5386-5390.
105.
105. Nagasawa H, Aoki M, Sakagami N, et al. Medroxyprogesterone acetate enhances spontaneous mammary tumorigenesis and uterine adenomyosis in mice. Breast Cancer Res Treat1988;12:59-66.
106.
106. Medina D. The mammary gland: A unique organ for the study of development and tumorigenesis. J Mammary Gland Biol Neoplasia1996;1:5-19.
107.
107. Bozie CR, Gerard NP, Von Uexkull-Guldenband C, et al. The murine interleukin-8 tye B receptor homologue and its ligands. J Biol Chem1994;269:29355-29358.
108.
108. Shyamala G, Yang X, Silberstein G, et al. Transgenic mice carrying an imbalance in the native-ratio of A to B forms of progesterone receptor exhibit development abnormalities in mammary glands. Proc Natl Acad Sci USA1998;95:696-701.
109.
109. Miller MM, James RA, Richer JK, et al. Progesterone regulated expression of flavin- containing monooxygenase 5 by the Bisoform of progesterone receptors: Implications for tamoxifen carcinogenicity. J Clin Endocrinol Metab1997;82:2956-2961.
110.
110. Maclusky NJ, McEwen BS. Progestin receptors in the developing rat brain and pituitary. Brain Res1980;189:262-268.
111.
111. Lauber AH, Romano GJ, Pfaff DW. Sex difference in estradiol regulation of progestin receptor mRNA in rat mediobasal hypothalamus as demonstrated by in situ hybridization. Neuroendocrinology1991;53:608-613.
112.
112. Lauber AH, Romano GJ, Pfaff DW. Steroid control of higher brain functions; Gene expression for estrogen and progesterone receptor mRNAs in rat brain and possible relations to sexually dimorphic functions. J Steroid Biochem Mol Biol1991;40:53-62.
113.
113. McEwen BS, Jones K, Pfaff DW. Hormonal control of sexual behavior in the female rat: Molecular, cellular and neurochemical studies. Biol Reprod1987;36:37-45.
114.
114. Mani SK, Blaustein JD, Allen JM, et al. Inhibition of rat sexual behavior by antisense oligonucleotides to the progesterone receptor. Endocrinology1994;135:1409-1414.
